Feasibility of <sup>18</sup>F-FDG Labelling of Leucocytes in a Centre Without an On-Site Cyclotron and Monitoring of Radiation Dose to Occupational Worker in the Labelling Procedure.

Thakral, Parul; Manda, Divya; Das, Subha Shankar; Tandon, Pankaj; Cb, Virupakshappa; Malik, Dharmender; Sen, Ishita

Feasibility of ¹⁸F-FDG Labelling of Leucocytes in a Centre Without an On-Site Cyclotron and Monitoring of Radiation Dose to Occupational Worker in the Labelling Procedure.

Thakral, Parul; Manda, Divya; Das, Subha Shankar; Tandon, Pankaj; Cb, Virupakshappa; Malik, Dharmender; Sen, Ishita.

Afiliação

Thakral P; Department of Nuclear Medicine, Fortis Memorial Research Institute, Gurgaon, India.
Manda D; Department of Nuclear Medicine, Fortis Memorial Research Institute, Gurgaon, India.
Das SS; Department of Nuclear Medicine, Fortis Memorial Research Institute, Gurgaon, India.
Tandon P; Radiological Safety Division and Central Public Information Officer, Atomic Energy Regulatory Board, Mumbai, India.
Cb V; Department of Nuclear Medicine, Fortis Memorial Research Institute, Gurgaon, India.
Malik D; Department of Nuclear Medicine, Fortis Memorial Research Institute, Gurgaon, India.
Sen I; Department of Nuclear Medicine, Fortis Memorial Research Institute, Gurgaon, India.

Cancer Biother Radiopharm ; 38(1): 8-14, 2023 Feb.

Article em En | MEDLINE | ID: mdl-35763304

Assuntos

Fluordesoxiglucose F18; Compostos Radiofarmacêuticos; Humanos; Ciclotrons; Estudos de Viabilidade; Leucócitos; Doses de Radiação; Tomografia por Emissão de Pósitrons/métodos

Palavras-chave

18F-FDG; 18F-FDG-leucocytes; infection; personnel monitoring

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Radiofarmacêuticos / Fluordesoxiglucose F18 Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google